Kindlin-1 Regulates Epidermal Growth Factor Receptor Signaling.
Blister
/ genetics
Cell Line
Cell Movement
EGF Family of Proteins
/ metabolism
Epidermolysis Bullosa
/ genetics
ErbB Receptors
/ metabolism
Humans
Keratinocytes
/ pathology
Lysosomes
/ metabolism
Membrane Proteins
/ genetics
Neoplasm Proteins
/ genetics
Periodontal Diseases
/ genetics
Photosensitivity Disorders
/ genetics
Proteolysis
Signal Transduction
Skin
/ pathology
Journal
The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
07
05
2018
revised:
09
08
2018
accepted:
10
08
2018
pubmed:
25
9
2018
medline:
1
1
2020
entrez:
25
9
2018
Statut:
ppublish
Résumé
Kindler syndrome is an autosomal recessive genodermatosis that results from mutations in the FERMT1 gene encoding t kindlin-1. Kindlin-1 localizes to focal adhesion and is known to contribute to the activation of integrin receptors. Most cases of Kindler syndrome show a reduction or complete absence of kindlin-1 in keratinocytes, resulting in defective integrin activation, cell adhesion, and migration. However, roles for kindlin-1 beyond integrin activation remain poorly defined. In this study we show that skin and keratinocytes from Kindler syndrome patients have significantly reduced expression levels of the EGFR, resulting in defective EGF-dependent signaling and cell migration. Mechanistically, we show that kindlin-1 can associate directly with EGFR in vitro and in keratinocytes in an EGF-dependent, integrin-independent manner and that formation of this complex is required for EGF-dependent migration. We further show that kindlin-1 acts to protect EGFR from lysosomal-mediated degradation. This shows a new role for kindlin-1 that has implications for understanding Kindler syndrome disease pathology.
Identifiants
pubmed: 30248333
pii: S0022-202X(18)32587-9
doi: 10.1016/j.jid.2018.08.020
pmc: PMC6345584
pii:
doi:
Substances chimiques
EGF Family of Proteins
0
FERMT1 protein, human
0
Membrane Proteins
0
Neoplasm Proteins
0
EGFR protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
369-379Subventions
Organisme : Medical Research Council
ID : MR/M018512/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N007336/1
Pays : United Kingdom
Informations de copyright
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Références
J Invest Dermatol. 2014 Oct;134(10):2570-2578
pubmed: 24691054
J Mol Biol. 2009 Dec 18;394(5):944-56
pubmed: 19804783
J Periodontol. 2008 May;79(5):961-6
pubmed: 18454678
Acta Derm Venereol. 2011 May;91(3):267-70
pubmed: 21336475
Nat Cell Biol. 2003 May;5(5):447-53
pubmed: 12717446
J Cell Biol. 2010 Apr 19;189(2):369-83
pubmed: 20404115
J Biol Chem. 2012 Apr 20;287(17):13799-812
pubmed: 22351767
J Cell Sci. 2017 Dec 15;130(24):4087-4096
pubmed: 29180516
Br J Dermatol. 2009 Feb;160(2):233-42
pubmed: 19120339
Hum Mutat. 2011 Nov;32(11):1204-12
pubmed: 21936020
Dev Cell. 2007 Oct;13(4):496-510
pubmed: 17925226
EMBO Rep. 2008 Dec;9(12):1203-8
pubmed: 18997731
Trends Cell Biol. 2009 Oct;19(10):504-13
pubmed: 19766491
Am J Hum Genet. 2003 Jul;73(1):174-87
pubmed: 12789646
Curr Biol. 2012 Sep 11;22(17):R673-5
pubmed: 22974990
Annu Rev Physiol. 2014;76:275-300
pubmed: 24215440
Sci Rep. 2018 Mar 21;8(1):4977
pubmed: 29563556
J Cell Sci. 2014 Oct 1;127(Pt 19):4308-21
pubmed: 25086068
Cancer Lett. 2015 Jun 1;361(2):271-81
pubmed: 25790908
J Biol Chem. 2013 Dec 6;288(49):35604-16
pubmed: 24165133
Nat Protoc. 2014 Mar;9(3):586-96
pubmed: 24525752
Opt Express. 2012 Feb 27;20(5):4957-67
pubmed: 22418300
J Cell Sci. 2012 May 1;125(Pt 9):2172-84
pubmed: 22328497
J Cell Biol. 2012 May 14;197(4):477-86
pubmed: 22564415
J Biol Chem. 2012 Aug 10;287(33):27345-58
pubmed: 22718763
J Biol Chem. 2012 Mar 2;287(10):6979-90
pubmed: 22235127
J Cell Sci. 2016 Jan 1;129(1):17-27
pubmed: 26729028
Hum Mol Genet. 2003 Apr 15;12(8):925-35
pubmed: 12668616
Biochim Biophys Acta. 2014 Feb;1838(2):605-19
pubmed: 23747363
J Invest Dermatol. 2008 Sep;128(9):2156-65
pubmed: 18528435
FEBS Lett. 2015 Jul 8;589(15):2001-10
pubmed: 26037143
Clin Exp Dermatol. 2004 Mar;29(2):116-21
pubmed: 14987263
J Biol Chem. 2003 Aug 1;278(31):28950-60
pubmed: 12754251
J Invest Dermatol. 2007 Sep;127(9):2268-70
pubmed: 17460733
J Biol Chem. 2014 Nov 7;289(45):31001-13
pubmed: 25237194
Br J Dermatol. 2008 Nov;159(5):1192-6
pubmed: 18652585
J Biol Chem. 2006 Nov 24;281(47):36082-90
pubmed: 17012746
J Invest Dermatol. 2016 Nov;136(11):2229-2239
pubmed: 27427485
J Biol Chem. 2010 Jun 11;285(24):18640-9
pubmed: 20378539